Marc Goodman Score: 38
Analyst at
Leerink Partners,
SVB Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+71.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
73%
8 W / 3 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
80%
4 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 5 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 5 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
63%
5 W / 3 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
7 W / 3 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 03, 2026 |
Biohaven Ltd
BHVN
|
BUY |
$15.00
Est. +41%
|
$10.67 | $12.10 |
Pending
|
$11.28
+5.7%
|
| Jan 12, 2026 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$8.00
Est. +252%
|
$2.27 | $3.65 |
Pending
|
$1.78
-21.6%
|
| Nov 21, 2025 |
MapLight Therapeutics, Inc.
MPLT
|
BUY |
$30.00
Est. +126%
|
$13.29 | $33.28 |
Target Met
|
$27.75
+108.8%
|
| May 06, 2025 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$10.00
Est. +115%
|
$4.65 | $18.61 |
Target Met
|
$14.59
+213.8%
|
| Oct 18, 2024 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$4.00
Est. +2%
|
$3.92 | $15.93 |
Target Met
|
$14.59
+272.2%
|
| Oct 11, 2024 |
Stoke Therapeutics Inc
STOK
|
BUY |
$18.00
Est. +52%
|
$11.84 | $32.40 |
Target Met
|
$29.82
+151.9%
|
| Sep 24, 2024 |
Biohaven Ltd
BHVN
|
BUY |
$60.00
Est. +36%
|
$44.22 | $55.58 |
Miss
|
$11.28
-74.5%
|
| Nov 02, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
SELL |
$115.00
Est. +4%
|
$119.36 | - | - |
$159.76
-33.8%
|
| Feb 28, 2022 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$31.00
Est. +22%
|
$25.41 | - | - |
$21.09
-17.0%
|
| Feb 24, 2022 |
Sage Therapeutics Inc
SAGE
|
BUY |
$50.00
Est. +44%
|
$34.71 | - | - |
$8.68
-75.0%
|
| Feb 11, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$100.00
Est. +17%
|
$85.53 | - | - |
$159.76
+86.8%
|
Biohaven Ltd
BHVN
Mar 03, 2026
Signal & Target
BUY
$15.00
Start Price
$10.67
Best Price (1Y)
$12.10
Current Price
$11.28
Return
+5.7%
Neumora Therapeutics Inc.
NMRA
Jan 12, 2026
Signal & Target
BUY
$8.00
Start Price
$2.27
Best Price (1Y)
$3.65
Current Price
$1.78
Return
-21.6%
MapLight Therapeutics, Inc.
MPLT
Nov 21, 2025
Signal & Target
BUY
$30.00
Start Price
$13.29
Best Price (1Y)
$33.28
Current Price
$27.75
Return
+108.8%
Amylyx Pharmaceuticals Inc
AMLX
May 06, 2025
Signal & Target
BUY
$10.00
Start Price
$4.65
Best Price (1Y)
$18.61
Current Price
$14.59
Return
+213.8%
Amylyx Pharmaceuticals Inc
AMLX
Oct 18, 2024
Signal & Target
BUY
$4.00
Start Price
$3.92
Best Price (1Y)
$15.93
Current Price
$14.59
Return
+272.2%
Stoke Therapeutics Inc
STOK
Oct 11, 2024
Signal & Target
BUY
$18.00
Start Price
$11.84
Best Price (1Y)
$32.40
Current Price
$29.82
Return
+151.9%
Biohaven Ltd
BHVN
Sep 24, 2024
Signal & Target
BUY
$60.00
Start Price
$44.22
Best Price (1Y)
$55.58
Current Price
$11.28
Return
-74.5%
Neurocrine Biosciences, Inc.
NBIX
Nov 02, 2022
Signal & Target
SELL
$115.00
Start Price
$119.36
Best Price (1Y)
-
Current Price
$159.76
Return
-33.8%
Acadia Pharmaceuticals Inc
ACAD
Feb 28, 2022
Signal & Target
BUY
$31.00
Start Price
$25.41
Best Price (1Y)
-
Current Price
$21.09
Return
-17.0%
Sage Therapeutics Inc
SAGE
Feb 24, 2022
Signal & Target
BUY
$50.00
Start Price
$34.71
Best Price (1Y)
-
Current Price
$8.68
Return
-75.0%
Neurocrine Biosciences, Inc.
NBIX
Feb 11, 2022
Signal & Target
BUY
$100.00
Start Price
$85.53
Best Price (1Y)
-
Current Price
$159.76
Return
+86.8%